Marianne PirardNaomi IihoshiMarleen BoelaertPaulino BasantaFrancisco Gomez LopezPatrick Van der Stuyft2026-03-222026-03-22200510.1111/j.0041-1132.2005.04214.xhttps://doi.org/10.1111/j.0041-1132.2005.04214.xhttps://andeanlibrary.org/handle/123456789/44281Citaciones: 80Routine blood donor screening for T. cruzi with a single test results in unacceptable numbers of false-negative samples in highly endemic areas or in at risk population groups. Adding a second test seems mandatory, but which one to choose depends on local cost components and feasibility.enMedicineSerologyTrypanosoma cruziPopulationChagas diseaseImmunologyarticle